Back to search

Article

Rituximab tunes desmoglein-3-specific follicular T cells in patients with pemphigus vulgaris

2023-04-26

Abstract excerpt

<h4>Background: </h4> : Pemphigus vulgaris (PV) is characterized by pathogenic auto-antibodies targeting interkeratinocytes desmoglein (Dsg) 1 and 3, and by the HLA-DRB1-0402 predisposition allele. Treatment using rituximab (RTX) combined with short-term corticosteroids (CS) allows disease control and long-lasting remission. The aim of this study is to evaluate the impact of RTX on the circulating subpopulations o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ef84b48-e5ee-55b0-959d-a7acfc0e843c
DOI
10.22541/au.168252564.46952044/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rituximab tunes desmoglein-3-specific follicular T cells in patients with pemphigus vulgarisDOI 10.22541/au.168252564.46952044/v1
Select a neighboring publication to make it the new centre.